Association between TGFBR1 polymorphisms and cancer risk: A meta-analysis of 35 case-control studies

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Wang, Yong qiang ^a   Qi, Xiao wei ^a   Wang, Fan ^b   Jiang, Jun ^a   Guo, Qiao nan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Jiangjin Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; OVARY CANCER; TBFBR1 GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; NEOPLASMS; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK;

EID: 84864688229     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042899     Document Type: Article

References (62)

1. Bredberg A, (2011) Cancer: More of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer 117: 440-445.
2. Hoeijmakers JHJ, (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374.
3. Pharoah PDP, Dunning AM, Ponder BAJ, Easton DF, (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4: 850-860.
4. Moses HL, Branum EL, Proper JA, Robinson RA, (1981) Transforming growth factor production by chemically transformed cells. Cancer Res 41: 2842-2848.
5. Roberts AB, Anzano MA, Lamb LC, (1981) New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A 78: 5339-5343.
6. Gordon KJ, Blobe GC, (2008) Role of transforming growth factor-(beta) superfamily signaling pathways in human disease. Biochim Biophys Acta 1782: 197-228.
7. Benson JR, (2004) Role of transforming growth factor (beta) in breast carcinogenesis. Lancet Oncol 5: 229-239.
8. Elliott RL, Blobe GC, (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23: 2078-2093.
9. Bierie B, Moses HL, (2006) Tumour microenvironment- TGFB: The molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520.
10. Galliher AJ, Neil JR, Schiemann WP, (2006) Role of transforming growth factor-beta in cancer progression. Future Oncol 2: 743-763.
11. Pasche B, Luo Y, Rao PH, Nimer SD, Dmitrovsky E, et al. (1998) Type I transforming growth factor (beta) receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 58: 2727-2732.
12. Chen T, Jackson C, Costello B, Singer N, Colligan B, et al. (2004) An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 112: 420-425.
13. Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, et al. (2005) Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 294: 1634-1646.
14. Liao RY, Mao C, Qiu LX, Ding H, Chen Q, et al. (2010) TGFBR1*6A/9A polymorphism and cancer risk: A meta-analysis of 13,662 cases and 14,147 controls. Mol Biol Rep 37: 3227-3232.
15. Dai L, Gast A, Horska A, Schrappe M, Bartram CR, et al. (2009) A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-(beta) and receptor genes. Pediatr Blood Cancer 52: 819-823.
16. Carvajal-Carmona LG, Churchman M, Bonilla C, Walther A, Lefevre JH, et al. (2010) Comprehensive assessment of variation at the transforming growth factor (beta) type 1 receptor locus and colorectal cancer predisposition. Pro Natl Acad Sci U S A 107: 7858-7862.
17. Forsti A, Li X, Wagner K, Tavelin B, Enquist K, et al. (2010) Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression. Genes Chromosomes Cancer 49: 270-281.
18. Hu YS, Pan Y, Li WH, Zhang Y, Li J, et al. (2010) Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study. BMC Cancer 10: 169.
19. Abuli A, Fernandez-Rozadilla C, Giraldez MD, Muoz J, Gonzalo V, et al. (2011) A two-phase case-control study for colorectal cancer genetic susceptibility: Candidate genes from chromosomal regions 9q22 and 3q22. Br J Cancer 105: 870-875.
20. Dong ZM, (2011) Correlation of TGF-β receptor type 1 gene 6A and Int7G24A polymorphisms with the risk of esophageal squamous cell carcinoma. Carcinogenesis,Teratogenesis & Mutagenesis 23: 16-21.
21. Guo W, Dong Z, Guo Y, Chen Z, Yang Z, et al. (2011) Association of polymorphisms in transforming growth factor-(beta) receptors with susceptibility to gastric cardia adenocarcinoma. Mol Biol Rep 39: 4301-4309.
22. Joshi NN, Kale MD, Hake SS, Kannan S, (2011) Transforming growth factor (beta) signaling pathway associated gene polymorphisms may explain lower breast cancer risk in western Indian women. PLoS One 6: e21866.
23. Martinez-Canto A, Castillejo A, Mata-Balaguer T, Castillejo MI, Hernandez-Illan E, et al. (2012) TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer. PLoS One 7: e30812.
24. Zhang HT, (2005) Int7G24A variant of the TGFBR1 gene and cancer risk: A meta-analysis of three case-control studies. Lung Cancer 49: 419-420.
25. Zhang X, Wu L, Sheng Y, Zhou W, Huang Z, et al. (2012) The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis. Mol Biol Rep 39: 2567-2574.
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 283: 2008-2012.
27. Little J, Bradley L, Bray MS, Clyne M, Dorman J, et al. (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156: 300-310.
28. Qi X, Ma X, Yang X, Fan L, Zhang Y, et al. (2010) Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: A meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat 123: 499-506.
29. Qi X, Zhang F, Yang X, Fan L, Zhang Y, et al. (2010) Transforming growth factor-(beta)1 polymorphisms and breast cancer risk: A meta-analysis based on 27 case-control studies. Breast Cancer Res Treat 122: 273-279.
30. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
31. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
32. DerSimonian R, Kacker R, (2007) Random-effects model for meta-analysis of clinical trials: An update. Contemp Clin Trials 28: 105-114.
33. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
34. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
35. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
36. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, et al. (1999) T(beta)R-I(6A) is a candidate tumor susceptibility allele. Cancer Res 59: 5678-5682.
37. Chen T, (1999) Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 82(1): 43-51.
38. van Tilborg AA, de Vries A, Zwarthoff EC, (2001) The chromosome 9q genes TGFBRI, TSCI, and ZNFI89 are rarely mutated in bladder cancer. J Pathol 194: 76-80.
39. Stefanovska AM, Efremov GD, Dimovski AJ, Jasar D, Zografski G, et al. (2001) TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Cancer Res 61: 8351-8352.
40. Samowitz WS, Curtin K, Leppert MF, Slattery ML, (2001) Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer. Genes Chromosomes Cancer 32: 381-383.
41. Baxter SW, Choong DYH, Eccles DM, Campbell IG, (2002) Transforming growth factor (beta) receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 11: 211-214.
42. Kaklamani V, Baddi L, Rosman D, Liu J, Ellis N, et al. (2004) No major association between TGFBR1*6A and prostate cancer. BMC Genet 5: 28.
43. Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, et al. (2004) TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J clin oncol 22: 756-758.
44. Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, et al. (2004) Polymorphisms and haplotype structures in genes for transforming growth factor (beta)1 and its receptors in familial and unselected breast cancers. Int J Cancer 112: 94-99.
45. Suarez BK, Pal P, Jin CH, Kaushal R, Sun G, et al. (2005) TGFBR1*6A is not associated with prostate cancer in men of European ancestry. Prostate Cancer Prostatic Dis 8: 50-53.
46. Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, et al. (2005) Transforming growth factor (beta) receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. Gynecol Oncol 97: 543-549.
47. Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, et al. (2005) Combined genetic assessment of transforming growth factor-(beta) signaling pathway variants may predict breast cancer risk. Cancer Res 65: 3454-3461.
48. Chen T, Jackson CR, Link A, Markey MP, Colligan BM, et al. (2006) Int7G24A variant of transforming growth factor-(beta) receptor type I is associated with invasive breast cancer. Clinical Cancer Res 12: 392-397.
49. Feigelson HS, Patel AV, Ryan Diver W, Stevens VL, Thun MJ, et al. (2006) Transforming growth factor (beta) receptor type I and transforming growth factor (beta)1 polymorphisms are not associated with postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 15: 1236-1237.
50. You W, Liu Z, Zhao J, Zheng M, Zheng SY, et al. (2007) No association between TGFBR1*6A and lung cancer. J Thorac Oncol 2: 657-659.
51. Cox DG, Penney K, Guo Q, Hankinson SE, Hunter DJ, (2007) TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study. BMC Cancer 7: 175.
52. Song B, Margolin S, Skoglund J, Zhou X, Rantala J, et al. (2007) TGFBR1*6A and Int7G24A variants of transforming growth factor-(beta) receptor 1 in Swedish familial and sporadic breast cancer. Br J Cancer 97: 1175-1179.
53. Skoglund J, Song B, Dalen J, Dedorson S, Edler D, et al. (2007) Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res 13: 3748-3752.
54. Skoglund Lundin J, Vandrovcova J, Song B, Zhou X, Zelada-Hedman M, et al. (2009) TGFBR1 variants TGFBR1*6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 100: 1674-1679.
55. Castillejo A, Rothman N, Murta-Nascimento C, Malats N, Garcia-Closas M, et al. (2009) TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. Int J Cancer 124: 608-613.
56. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, et al. (2010) BRCA1-associated breast and ovarian cancer risks in Poland: No association with commonly studied polymorphisms. Breast Cancer Res Treat 119: 201-211.
57. Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, et al. (2010) The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Res Treat 119: 437-442.
58. Castillejo A, Mata-Balaguer T, Guarinos C, Castillejo MI, Martinez-Canto A, et al. (2009) The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study. BMC Cancer 9: 406.
59. Zhang Y, Liu B, Jin M, Ni Q, Liang X, et al. (2009) Genetic polymorphisms of transforming growth factor-(beta)1 and its receptors and colorectal cancer susceptibility: A population-based case-control study in China. Cancer Lett 275: 102-108.
60. Hu YS, Pan Y, Li WH, Zhang Y, Li J, et al. (2011) Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population. Med Oncol 28: 622-625.
61. Zhang Y, (2011) Need for clarification of data in the recent meta-analysis about TGFBR1*6A/9A polymorphism and breast cancer risk. Breast Cancer Res Treat 130: 1073-1074.
62. Castillejo A, Mata-Balaguer T, Montenegro P, Ochoa E, Lazaro R, et al. (2009) The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: A case-control study. BMC Cancer 9: 193.